Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep689 | Female Reproduction | ECE2016

Body composition in lean women with polycystic ovary syndrome (PCOS) in relation to lipids and insulin resistance

Bogavac Tamara , Bozic-Antic Ivana , Ilic Dusan , Bjekić-Macut Jelica , Vojnovic-Milutinovic Danijela , Popovic Bojana , Isailovic Tatjana , Elezovic Valentina , Ognjanovic Sanja , Stanojlovic Olivera , Damjanovic Svetozar , Macut Djuro

Introduction: PCOS women appear to have an adverse body composition (BC). The aim of this study was to compare BC in lean PCOS in comparison to controls and to assess possible metabolic consequences.Methods: We evaluated 150 lean PCOS women (BMI: 20.96±2.06 kg/m2; age: 25.50±4.52 years) diagnosed using ESHRE/ASRM criteria, and 39 lean BMI-matched healthy women (BMI: 20.33±2.16 kg/m2; age: 27.67±5.39 years). BC wa...

ea0099ep437 | Reproductive and Developmental Endocrinology | ECE2024

PCOS-like syndrome in the young woman with cortisone reductase deficiency type 1

Krstic Katarina , Ognjanovic Sanja , Popovic Bojana , Ilic Dusan , Elezovic Kovacevic Valentina , Bjekić Macut Jelica , Opalic Palibrk Milica , Radic Lena , Stanojlović Olivera , Rasic Markovic Aleksandra , Vojnovic Milutinovic Danijela , Macut Djuro

Introduction: 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a dimeric enzyme that catalyzes the reduction of cortisone to cortisol within the endoplasmic reticulum. Loss of this activity results in a disorder termed cortisone reductase deficiency type 1 (CRD). Only mutations in H6PD gene, which encodes an enzyme supplying cofactor for the reaction, have been identified as the cause of disease. Biochemical features of CRD are increased cortisol clearance and A...